Hollsteen
← NXP

Cash and equivalents

Balance – as of period end · $M

QuartersFiscal years

$MCash and equivalents · Q1 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Cash and equivalents · Q2 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Cash and equivalents · Q3 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Cash and equivalents · Q4 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Cash and equivalents · Q1 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Cash and equivalents · Q2 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Cash and equivalents · Q3 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Cash and equivalents · Q4 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Cash and equivalents · Q1 2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Cash and equivalents · Q2 2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Cash and equivalents · Q3 2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Cash and equivalents · Q4 2018: $2.8B · 10-K 0001413447-20-000009 filed Feb 27, 2020Cash and equivalents · Q1 2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Cash and equivalents · Q2 2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Cash and equivalents · Q3 2019: $3.5B · 10-Q 0001413447-19-000035 filed Oct 29, 2019Cash and equivalents · Q4 2019: $1.0B · 10-K 0001413447-20-000009 filed Feb 27, 2020Cash and equivalents · Q1 2020: $1.1B · 10-Q 0001413447-20-000026 filed Apr 28, 2020Cash and equivalents · Q2 2020: $3.3B · 10-Q 0001413447-20-000056 filed Jul 28, 2020Cash and equivalents · Q3 2020: $3.6B · 10-Q 0001413447-20-000084 filed Oct 27, 2020Cash and equivalents · Q4 2020: $2.3B · 10-K 0001413447-21-000011 filed Feb 25, 2021Cash and equivalents · Q1 2021: $1.8B · 10-Q 0001413447-21-000032 filed Apr 27, 2021Cash and equivalents · Q2 2021: $2.9B · 10-Q 0001413447-21-000062 filed Aug 3, 2021Cash and equivalents · Q3 2021: $2.3B · 10-Q 0001413447-21-000094 filed Nov 2, 2021Cash and equivalents · Q4 2021: $2.8B · 10-K 0001413447-22-000008 filed Feb 24, 2022Cash and equivalents · Q1 2022: $2.7B · 10-Q 0001413447-22-000014 filed May 3, 2022Cash and equivalents · Q2 2022: $3.5B · 10-Q 0001413447-22-000049 filed Jul 26, 2022Cash and equivalents · Q3 2022: $3.8B · 10-Q 0001413447-22-000067 filed Nov 1, 2022Cash and equivalents · Q4 2022: $3.8B · 10-K 0001413447-23-000006 filed Mar 1, 2023Cash and equivalents · Q1 2023: $3.9B · 10-Q 0001413447-23-000020 filed May 2, 2023Cash and equivalents · Q2 2023: $3.9B · 10-Q 0001413447-23-000059 filed Jul 25, 2023Cash and equivalents · Q3 2023: $4.0B · 10-Q 0001413447-23-000107 filed Nov 7, 2023Cash and equivalents · Q4 2023: $3.9B · 10-K 0001413447-24-000013 filed Feb 22, 2024Cash and equivalents · Q1 2024: $2.9B · 10-Q 0001413447-24-000038 filed Apr 30, 2024Cash and equivalents · Q2 2024: $2.9B · 10-Q 0001413447-24-000072 filed Jul 23, 2024Cash and equivalents · Q3 2024: $2.7B · 10-Q 0001413447-24-000089 filed Nov 5, 2024Cash and equivalents · Q4 2024: $3.3B · 10-K 0001413447-25-000019 filed Feb 20, 2025Cash and equivalents · Q1 2025: $4.0B · 10-Q 0001413447-25-000031 filed Apr 29, 2025Cash and equivalents · Q2 2025: $3.2B · 10-Q 0001413447-25-000106 filed Jul 24, 2025Cash and equivalents · Q3 2025: $3.5B · 10-Q 0001413447-25-000120 filed Oct 28, 2025Cash and equivalents · Q4 2025: $3.3B · 10-K 0001413447-26-000008 filed Feb 19, 2026Cash and equivalents · Q1 2026: $3.7B · 10-Q 0001413447-26-000034 filed Apr 28, 2026missing3,7082,7894,042Q1 2016Q1 2026Q1 2021
$MCash and equivalents · Q2 2024: $2.9B · 10-Q 0001413447-24-000072 filed Jul 23, 2024Cash and equivalents · Q3 2024: $2.7B · 10-Q 0001413447-24-000089 filed Nov 5, 2024Cash and equivalents · Q4 2024: $3.3B · 10-K 0001413447-25-000019 filed Feb 20, 2025Cash and equivalents · Q1 2025: $4.0B · 10-Q 0001413447-25-000031 filed Apr 29, 2025Cash and equivalents · Q2 2025: $3.2B · 10-Q 0001413447-25-000106 filed Jul 24, 2025Cash and equivalents · Q3 2025: $3.5B · 10-Q 0001413447-25-000120 filed Oct 28, 2025Cash and equivalents · Q4 2025: $3.3B · 10-K 0001413447-26-000008 filed Feb 19, 2026Cash and equivalents · Q1 2026: $3.7B · 10-Q 0001413447-26-000034 filed Apr 28, 20263,7082,8593,988Q2 2024Q1 2026Q2 2025
Q1 2026
3,708$M
All values (28)
PeriodValue ($M)Status
Q1 20263,708reported
Q4 20253,267reported
Q3 20253,454reported
Q2 20253,170reported
Q1 20253,988reported
Q4 20243,292reported
Q3 20242,748reported
Q2 20242,859reported
Q1 20242,908reported
Q4 20233,862reported
Q3 20234,042reported
Q2 20233,863reported
Q1 20233,930reported
Q4 20223,845reported
Q3 20223,759reported
Q2 20223,545reported
Q1 20222,683reported
Q4 20212,830reported
Q3 20212,303reported
Q2 20212,910reported
Q1 20211,842reported
Q4 20202,275reported
Q3 20203,566reported
Q2 20203,266reported
Q1 20201,079reported
Q4 20191,045reported
Q3 20193,537reported
Q4 2018Noneerror

13 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: cash

More metrics for NXP

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$3.7B
Period
Q1 2026, ended Mar 29, 2026 · as of Mar 29, 2026 (balance as of date, not a sum)
Source
10-Q, filed Apr 28, 2026 · 0001413447-26-000034
Location
us-gaap:CashAndCashEquivalentsAtCarryingValue
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$3.7BApr 28, 202610-Q 0001413447-26-000034reported · confidence 1. · current